FIELD: medicine.
SUBSTANCE: individual quantitative assessment of risk of developing atherosclerosis manifestations is ensured by preliminary screening study with evaluating the biochemical, immunological, physiological and clinical indices to be subjected to the discriminant analysis. Weighting coefficients and an offset constant are derived for each index. The values of integral health level index are determined for each examined patient as a weighed total of all derived indices multiplied by the relevant weighting factor and the added offset constant. The dependence of the prevalence on said integral index is established. The operative stage of said method involves evaluating the same indices as those from the preliminary stage. The derived indices are used to calculate the integral index with the weighting coefficients and the offset constant derived at the preliminary stage; the prevalence is determined by the dependence of the prevalence evaluated at the preliminary stage on the integral health level. The prevalence is used to assess risk of developing atherosclerosis manifestations.
EFFECT: method improves the information value and consistency of early assessment of risk of developing atherosclerosis manifestations.
2 cl, 1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INDIVIDUAL QUANTITATIVE ASSESSMENT OF ISCHEMIC HEART DISEASE DEVELOPMENT | 2012 |
|
RU2503405C1 |
METHOD FOR INDIVIDUAL ASSESSMENT OF PATIENTS TO ESTABLISH FACT OF CHRONIC CARDIAC INSUFFICIENCY SUFFERED | 2013 |
|
RU2550664C1 |
METHOD OF INDIVIDUAL QUANTITATIVE ASSESSMENT OF RISK OF HYPERTENSION DEVELOPMENT | 2012 |
|
RU2535025C2 |
METHOD FOR EVALUATING RISK OF CLINICAL COMPLICATIONS OF ATHEROSCLEROSIS | 2011 |
|
RU2498307C2 |
METHOD FOR PREDICTING THE INDIVIDUAL RISK OF INCREASING THE CARDIO-MALLEOLAR VASCULAR STRESS COMPLEX IN 6 MONTHS FROM THE START OF LIPID-LOWERING THERAPY | 2018 |
|
RU2680141C1 |
METHOD FOR PREDICTION OF THICKNESS OF INTIMA-MEDIA COMPLEX IN CHEMICAL INDUSTRY WORKERS | 2019 |
|
RU2704478C1 |
METHOD FOR DETERMINING RISK OF CORONARY ARTERY ATHEROSCLEROSIS IN PATIENTS SUFFERING FROM DIABETES MELLITUS ACCOMPANIED BY CARDIOVASCULAR DISORDERS | 2013 |
|
RU2532521C1 |
METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
METHOD FOR PREDICTION OF INCREASING ARTERIAL STIFFNESS IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK AND RECEIVING STATIN THERAPY | 2015 |
|
RU2584350C1 |
METHOD FOR PREDICTION OF EARLY POST-INFARCTION ANGINA IN PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION ACROSS STAYING IN HOSPITAL | 2014 |
|
RU2543356C1 |
Authors
Dates
2010-04-10—Published
2007-08-13—Filed